Alprazolam
| Disease area studied | Abbreviated title | Phase | Study ID | Registry database | Study results | Plain language summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Anxiety | Phase 3 |
SP0829
Completed |
NCT00139854 | ||||
| Mild Asthma | A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma | Phase 1 |
UP0099
Completed |
NCT04802746 | Miller S.D. et al. (2023) [abstract 2.255] 77th Annual Meeting of American Epilepsy Society (AES), December 01-05, 2023; Orlando, USA AES Annual Meeting Abstract Database. www.aesnet.org Miller S.D., et al. Neurology 2024; 102(17 Suppl.1), abs P9-1.009 76th Annual Meeting of American Academy of Neurology (AAN), April 13-18, 2024; Denver, USA | ||
| Epilepsy | A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy | Phase 1 |
UP0100
Completed |
NCT04857307 2022-002523-36 |
LINK
|
Klein P. et al. (2023) [abstract 2.261] 77th Annual Meeting of American Epilepsy Society (AES), December 01-05, 2023; Orlando, USA AES Annual Meeting Abstract Database. www.aesnet.org Klein P. et al. Neurology 2024; 102(17 Suppl.1), abs P9-1.002 76th Annual Meeting of American Academy of Neurology (AAN), April 13-18, 2024; Denver, USA | |
| Epilepsy | A Relative Bioavailability Study of Staccato Alprazolam Versus Oral Alprazolam in Healthy Study Participants | Phase 1 |
UP0104
Completed |
NCT05626439 |